Evaluation of novel optofluidics by biotechnology end-user
The aim of this project is to engage with researchers in the optofluidic field via the COST Action MP1205 and evaluate and apply new ideas to the technical problems faced in R&D in a biotechnology company. Oxford Gene Technology carries out internal R&D involving technologies such as microfluidics devices and single-molecule optical microscopy, and is working on molecular methods for diagnosis involving genomics as well as proteomics.
OGT company internal
Grant funding as appropriate
WG3: Materials (soft, bio and nano) and technologies for optofluidic devices